Items Tagged ‘Andrew Limper’
September 28, 2021 · Leave a Comment
By Advancing the Science contributor 
Andrew Limper, M.D., was the first named associate dean of Practice Transformation, in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. During his tenure with the center, and through his leadership, Mayo Clinic streamlined practice transformative research and discovery efforts across the institution into a single, […]
View full entry Comment on this
Tags: Andrew Limper, artificial intelligence, basic science, Ben Pollock, biostatistics, cardiology, Center for Clinical and Translational Science, Center for the Science of Health Care Delivery, clinical trials, COVID-10, Curt Storlie, discovery research
September 21, 2021 · Leave a Comment
Antifibrotics may extend lives for patients with IPF
Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of survival after a respiratory-related hospitalization compared to patients not receiving these medications. The study, which was supported by Three Lakes Foundation, was published recently in BMC Pulmonary Medicine. Read Three Lakes news release. […]
View full entry Comment on this
Tags: Andrew Limper, Center for the Science of Health Care Delivery, idiopathic pulmonary fibrosis, OptumLabs
June 15, 2021 · Leave a Comment
Transforming medicine for patients with respiratory diseases
The Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery provides a unique service for Mayo Clinic. Embedded in the medical practice, its objective is to transform the practice of medicine – from the inside out. Center researchers work within multidisciplinary teams to identify areas for improvement within […]
View full entry Comment on this
Tags: Aahd Kubbara, acute respiratory illness, Alanna Chamberlain, Andrew Limper, Ann Vu, antifungal, biomedical research, Cassie Kennedy, Center for the Science of Health Care Delivery, chronic obstructive pulmonary disease, COPD, COVID-19
September 20, 2019 · Leave a Comment
Good news about the effectiveness of antifibrotics for IPF
In a recent study published in the American Journal of Respiratory and Critical Care, a research team led by Andrew Limper, M.D., a pulmonology and critical care physician at Mayo Clinic, evaluated the effectiveness of pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. The researchers reported “the medications had an association with a reduced […]
View full entry Comment on this
Tags: Andrew Limper, Center for the Science of Health Care Delivery, clinical trials, idiopathic pulmonary fibrosis, OptumLabs